Form D · Pharmaceuticals
Radius Health, Inc.
Cambridge, MA · CIK 0001428522
Offering snapshot reported May 31, 2011 · SEC filing
- Reported sold
- $64.3M Offering amount: $64.3M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 17, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 31, 2011 | Initial | $64,285,446 | No comparison | 18 | SEC filing |
| May 31, 2011 | Initial | $126,880,217 | No comparison | 36 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $435K
- Finders' fees
- $0
- Form D file number
- 021-160578
Represents the total amount of securities to be sold under a stock purchase agreement whereby the Issuer will issue a capital call on the purchase price and issue the securities in three stages.
Series A-1 Convertible Preferred Stock
The amount in Item 15 is for sales commission on the first capital call received and does not reflect commissions on future capital calls.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Leerink Swann LLC | 39011 | Leerinks Swann LLC · CRD 39011 |
Source: Form D, filed May 31, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alan Auerbach | Director, Promoter |
| Jonathan Fleming | Director |
| Ansbert K. Gadicke | Director, Promoter |
| Kurt Graves | Director, Promoter |
| B. Nicholas Harvey | Executive, Promoter |
| Gary Hattersley | Executive, Promoter |
| C. Richard Lyttle | Director, Executive, Promoter |
| Martin Muenchbach | Director, Promoter |
| Louis O'dea | Executive, Promoter |
| Elizabeth Stoner | Director, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Attn: Chief Financial Officer 201 Broadway, 6 Th Floor
Cambridge, MA, 02139
Cambridge, MA, 02139